Individualized treatments for obesity based on mitochondrial biology

Acronym

MitoPower4WeightLoss

Description of the granted funding

Obesity is a major public health burden, and often difficult to treat. In addition to bariatric surgery, few treatment options provide effective and durable results. In this study, we aim to generate novel, personalised treatment strategies for obesity and related metabolic diseases. We base this proposal on the novel findings from our previous studies: the capacity of mitochondria, the respiratory engines of the cells, in subcutaneous fat tissue 1) predicts weight loss, 2) decreases after dieting, but highly increases after bariatric surgery. In the present proposal, we broaden the study of mitochondria to visceral and brown fat, muscle and liver and use bariatric surgery as a model to identify mechanisms for improving mitochondrial capacity in these tissues and thus, to improve weight loss and metabolic health. The outcomes of our study will ease the development of personalised treatments for obesity-related conditions.
Show more

Starting year

2021

End year

2022

Granted funding





Kirsi Pietiläinen Orcid -palvelun logo
100 000 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Helsinki (335445)
100 000 €
Partner
Turku University Central Hospital (335446)
100 000 €
Partner
100 000 €
Partner
University of Eastern Finland (335444)
100 000 €

Funder

Research Council of Finland

Funding instrument

Academy programme

Other information

Funding decision number

335443

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

lifestyle diseases